Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88.1M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
23.8M
-
Shares change
-
+3.32M
-
Total reported value, excl. options
-
$559M
-
Value change
-
+$80.3M
-
Put/Call ratio
-
0.82
-
Number of buys
-
47
-
Number of sells
-
-34
-
Price
-
$23.50
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2021
102 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q1 2021.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.8M shares
of 88.1M outstanding shares and own 27% of the company stock.
Largest 10 shareholders include Canaan Partners X LLC (2.66M shares), BVF INC/IL (2.61M shares), RTW INVESTMENTS, LP (2.47M shares), BOXER CAPITAL, LLC (2.2M shares), 5AM Venture Management, LLC (1.8M shares), FEDERATED HERMES, INC. (1.51M shares), Avidity Partners Management LP (1.47M shares), BlackRock Inc. (1.41M shares), PRICE T ROWE ASSOCIATES INC /MD/ (900K shares), and VANGUARD GROUP INC (879K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.